V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20202725 | 20167191 | 1.67 | 82.2 | null | 2018-08-13 | 2018-09-11 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | DOCETAXEL | 100398858 |
| 20202747 | 20167192 | 1.67 | 54.6 | Palliative (P) | 2020-08-19 | 2020-10-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101044291 |
| 20202761 | 20167193 | 1.63 | 116.5 | Palliative (P) | 2017-02-14 | 2017-07-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101095291 |
| 20202766 | 20167194 | 1.91 | null | null | 2016-05-26 | 2016-06-28 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101449440 |
| 20202775 | 20167195 | 1.63 | 76 | null | 2017-10-11 | 2017-10-14 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100634463 |
| 20202783 | 20167196 | 1.7 | 61.6 | null | 2020-11-26 | 2020-12-27 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101557139 |
| 20202784 | 20167197 | 1.54 | 143.7 | Palliative (P) | 2017-11-30 | 2017-12-11 | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100215588 |
| 20202789 | 20167198 | 1.68 | 67.4 | null | 2018-05-22 | 2018-05-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100228406 |
| 20202810 | 20167199 | 1.58 | 78.7 | Palliative (P) | 2019-03-30 | 2019-04-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101349493 |
| 20202812 | 20167200 | 1.68 | 81.4 | null | 2019-10-04 | 2019-10-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100134408 |
| 20202847 | 20167201 | 1.76 | 79 | null | 2020-04-02 | 2020-04-03 | CETUXIMAB + IRINOTECAN + MDG | N | null | DOCETAXEL | 101635771 |
| 20202851 | 20167202 | 1.74 | 51.2 | Palliative (P) | 2022-03-06 | 2022-03-06 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100576991 |
| 20202854 | 20167203 | 1.55 | 87 | Palliative (P) | 2017-12-30 | 2018-01-06 | Cetuximab + FLUOROURACIL + IRINOTECAN | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101768514 |
| 20202862 | 20167204 | 1.84 | 58.5 | Palliative (P) | 2017-07-21 | 2017-08-03 | CETUXIMAB + IRINOTECAN + MDG | N | N | CAPECITABINE + GEMCITABINE | 101645386 |
| 20202865 | 20167205 | null | 106 | null | 2016-11-03 | 2016-11-05 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100353527 |
| 20202869 | 20167206 | 1.71 | 63 | null | 2020-01-21 | 2020-07-23 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101203409 |
| 20202874 | 20167207 | 1.52 | 51.2 | Adjuvant (A) | 2020-03-09 | 2020-03-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101752602 |
| 20202883 | 20167208 | 1.76 | 54.4 | Adjuvant (A) | 2019-03-07 | 2019-03-28 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100114815 |
| 20202897 | 20167209 | 1.68 | 44.1 | null | 2018-08-21 | 2018-08-21 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100519243 |
| 20202900 | 20167210 | 1.63 | 64.4 | Palliative (P) | 2020-10-25 | 2020-11-21 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101198219 |
| 20202902 | 20167211 | 1.93 | 115.9 | Palliative (P) | 2022-03-22 | 2022-04-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100872284 |
| 20202904 | 20167212 | 1.87 | 56 | null | 2017-10-23 | 2017-10-30 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100393953 |
| 20202920 | 20167213 | 1.7 | 35 | Palliative (P) | 2020-03-01 | 2020-03-01 | Docetaxel | 02 | N | DOCETAXEL | 101156331 |
| 20202939 | 20167214 | 1.66 | 74.7 | null | 2021-08-02 | 2021-08-05 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101425264 |
| 20202965 | 20167215 | 1.6 | 81.05 | Palliative (P) | 2021-11-08 | 2021-11-13 | Docetaxel | 02 | N | DOCETAXEL | 101466978 |
| 20203031 | 20167216 | 1.75 | 66.9 | Palliative (P) | 2021-04-28 | 2021-05-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101006154 |
| 20203075 | 20167217 | 1.6 | 65 | null | 2018-08-11 | 2018-08-27 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101441223 |
| 20203081 | 20167218 | 1.53 | 52 | Palliative (P) | 2017-01-19 | 2017-01-26 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100419605 |
| 20203096 | 20167219 | 1.81 | 116.5 | Palliative (P) | 2019-06-14 | 2019-06-14 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100662275 |
| 20203114 | 20167220 | 1.7 | 87.6 | Palliative (P) | 2020-12-31 | 2021-01-01 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101062059 |
| 20203128 | 20167221 | 1.81 | 78.7 | Palliative (P) | 2018-12-25 | 2018-12-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100653950 |
| 20203152 | 20167222 | 1.7 | 37.4 | Palliative (P) | 2015-09-09 | 2017-01-08 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101432323 |
| 20203163 | 20167223 | 1.59 | 62.6 | Palliative (P) | 2018-11-19 | 2018-11-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101655143 |
| 20203168 | 20167224 | 1.67 | 66.7 | Palliative (P) | 2020-07-29 | 2020-07-31 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101081022 |
| 20203169 | 20167225 | 1.6 | 71.6 | Palliative (P) | 2021-07-16 | 2021-08-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100417943 |
| 20203191 | 20167226 | 1.81 | 82.8 | Palliative (P) | 2018-08-04 | 2018-08-04 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100164353 |
| 20203196 | 20167227 | 1.74 | 94.1 | Palliative (P) | 2020-04-18 | 2020-04-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100860048 |
| 20203197 | 20167228 | 1.79 | 52.5 | Adjuvant (A) | 2019-03-19 | 2019-07-05 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101138920 |
| 20203209 | 20167229 | 1.85 | 84.7 | Palliative (P) | 2020-04-13 | 2020-04-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101822119 |
| 20203212 | 20167230 | 1.7 | 70.5 | Palliative (P) | 2020-08-13 | 2021-02-21 | Cetuximab + FOLFIRI cycle 2 onwards | null | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100823329 |
| 20203221 | 20167231 | 0 | 47.6 | Palliative (P) | 2020-08-27 | 2020-09-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101427460 |
| 20203257 | 20167232 | 1.59 | 65 | Palliative (P) | 2019-09-24 | 2019-10-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101635842 |
| 20203259 | 20167233 | 1.69 | 80 | Palliative (P) | 2017-09-11 | 2017-11-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100628157 |
| 20203263 | 20167234 | 1.69 | 47.6 | null | 2020-10-25 | 2021-03-03 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100367377 |
| 20203288 | 20167235 | 1.81 | 105 | Palliative (P) | 2017-05-25 | 2017-06-01 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 101394527 |
| 20203305 | 20167236 | 1.85 | 112 | Palliative (P) | 2016-05-30 | 2016-06-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100290921 |
| 20203309 | 20167237 | 1.76 | 60.6 | Palliative (P) | 2020-08-17 | 2020-08-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100652956 |
| 20203319 | 20167238 | 1.67 | 82.6 | Palliative (P) | 2021-04-17 | 2021-04-21 | Cetuximab + FOLFIRI cycle1 | 02 | Y | CAPECITABINE + GEMCITABINE | 101819116 |
| 20203327 | 20167239 | 1.89 | 71.35 | Palliative (P) | 2017-10-26 | 2017-11-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100842997 |
| 20203335 | 20167240 | 1.74 | 54.15 | null | 2017-10-06 | 2018-03-10 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101155176 |